Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
Investors
Reports, Presentations & Fact sheet - latest
| Title: | |
|---|---|
4 abstracts presented at XIX World Congress on Parkinson's Disease and Related Disorders - Shanghai, China, December 11-14, 201113/12/2011 |  |
Transaction Overview (slides)27/09/2011 | |
Half Year Report 201109/09/2011 | |
MedPage Today interview with Ravi Anand14/04/2011 | |
63rd AAN Annual Meeting poster P05.287(safinamide)14/04/2011 | |
63rd AAN Annual Meeting late-breaking poster presentation (safinamide)13/04/2011 | |
63rd AAN Annual Meeting abstract P05.287 (safinamide)13/04/2011 | |
63rd AAN Annual Meeting abstract S33.002 (safinamide)13/04/2011 | |
AAN release13/04/2011 | |
Media, investors and analyst conference - 2010 results MP3 file06/04/2011 | |